Literature DB >> 12043987

The transverse dorsal approach to the Lisfranc joint.

Christopher J Vertullo1, Mark E Easley, James A Nunley.   

Abstract

While multiple longitudinal skin incisions can be utilized to visualize the joints of the midfoot, we feel that exposure can be difficult. Dorsal transverse and T incisions were undertaken to expose the tarsometatarsal joints (TMTJs) in 12 patients. Five of the 12 had some form of immunosuppression, including diabetes, methotrexate therapy and antirejection transplant therapy. One patient who had a lengthening of the midfoot with a structural autograft suffered a small area of skin necrosis that healed by secondary intention. The remainder of patient's wounds healed without complication. Three to six dorsal access intervals are created between the neurovascular and musculotendinous structures that overlie the TMTJs. The transverse incision can be extended into a medially based T incision to apply a medial plate as required. Transverse incisions are not recommended for patients who require lengthening of the midfoot.

Entities:  

Mesh:

Year:  2002        PMID: 12043987     DOI: 10.1177/107110070202300509

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  4 in total

1.  Surgical anatomy of the midfoot.

Authors:  Christopher J Pearce; James D Calder
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-03-10       Impact factor: 4.342

2.  Lisfranc injuries: an update.

Authors:  Kyriacos I Eleftheriou; Peter F Rosenfeld; James D F Calder
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-04-07       Impact factor: 4.342

3.  Reconstruction After Malunited Lisfranc Injuries.

Authors:  Thomas Mittlmeier; Patrick Haar; Markus Beck
Journal:  Eur J Trauma Emerg Surg       Date:  2010-06-01       Impact factor: 3.693

Review 4.  Lisfranc fracture-dislocations: current management.

Authors:  Inmaculada Moracia-Ochagavía; E Carlos Rodríguez-Merchán
Journal:  EFORT Open Rev       Date:  2019-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.